| Literature DB >> 26316244 |
Abstract
Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor and vaginal symptoms. Today, symptomatic women younger than 60 years of age or less than 10 years since onset of menopause yield the greatest benefit of MHT with the lowest risks when compared with older women remote from menopause. Careful assessment before initiating therapy includes severity of bothersome symptoms, treatment preferences, medical history, presence of contraindications to MHT, and personal risk of cardiovascular disease and breast cancer. Considerations of type of MHT, dosing, and route of administration, and recommendations regarding duration of therapy are discussed.Entities:
Keywords: Bazedoxifene; Estrogen; Menopausal hormone therapy; Ospemifene; Progestogen; Selective estrogen receptor modulator
Mesh:
Year: 2015 PMID: 26316244 DOI: 10.1016/j.ecl.2015.05.006
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741